Want to join the conversation?
In Consumer, $C expects to generate YoverY revenue growth in constant dollars across North America, Asia and Latin America in 4Q16, although sequentially mortgage activity could be seasonally slower versus 3Q16. In the Institutional, the company expects markets to reflect a normal seasonal decline from 3Q16, but sales still should improve YoverY.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?